Also trades as: GUD.TO (TSX) · $vol 1M
KHTRF OTC
Knight Therapeutics Inc.
1W: +4.0%
1M: +8.1%
3M: +8.1%
YTD: +71.7%
1Y: +69.0%
3Y: +106.3%
5Y: +73.7%
$7.47
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$70M
+93.6% ▲
Capital Expenditures
$2M
+93.9% ▲
5Y CAGR: -37.9%
Free Cash Flow
$68M
+1321.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$6M
+28.4% ▲
Net Change in Cash
$6K
-100.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $16M | -$30M | -$17M | $4M | -$5M |
| Depreciation & Amort. | $48M | $63M | $50M | $53M | $57M |
| Stock-Based Comp. | $3M | $2M | $2M | $2M | $0 |
| Change in Working Capital | $627K | -$10M | -$6M | -$20M | $2M |
| Other Non-Cash Items | -$15M | $33M | $15M | -$154K | $21M |
| Operating Cash Flow | $45M | $40M | $36M | $36M | $70M |
| — Investing Activities — | |||||
| Capital Expenditures | -$224M | -$26M | -$950K | -$2M | -$34M |
| Acquisitions (Net) | -$220M | $0 | $0 | $0 | -$110M |
| Investment Purchases | -$64M | -$185M | -$334M | -$163M | -$70M |
| Investment Sales | $181M | $151M | $348M | $211M | $112M |
| Other Investing | $223M | -$2M | $17M | -$29M | $18M |
| Investing Cash Flow | -$105M | -$63M | $29M | $17M | -$84M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$14M | $31M | -$18M | -$18M | $23M |
| Stock Repurchased | -$64M | -$30M | -$53M | -$9M | -$6M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $297K | -$4M | -$9M | -$7M | -$4M |
| Financing Cash Flow | -$78M | $2M | -$81M | -$34M | $13M |
| Net Change in Cash | -$144M | -$14M | -$13M | $21M | $6K |
| Cash End of Period | $86M | $72M | $59M | $80M | $76M |
| Free Cash Flow | -$180M | $15M | $26M | $5M | $68M |